Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carver

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Clinical Chemistry|July 30, 2015
Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and TrastuzumabMary Putt, Virginia Shalkey Hahn, James L Januzzi, et al.
Circulation. Cardiovascular Imaging|June 30, 2012
Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumabHeloisa Sawaya, Igal A Sebag, Juan Carlos Plana, et al.
Journal of the American College of Cardiology|December 3, 2013
Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumabBonnie Ky, Mary Putt, Heloisa Sawaya, et al.
JACC. Cardiooncology|October 4, 2021
Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology SocietyJoshua D Mitchell, Daniel A Cehic, Marita Morgia, et al.
Cancer|May 2, 2019
Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapyBiniyam G Demissei, Brian S Finkelman, Rebecca A Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2019
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple MyelomaRobert F Cornell, Bonnie Ky, Brendan M Weiss, et al.
Ecancermedicalscience|June 17, 2014
Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014)Michael Ewer, Luca Gianni, Fabrizio Pane, et al.
American Journal of Obstetrics and Gynecology|November 2, 2023
Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysisAli Javinani, Shohra Qaderi, Kamran Hessami, et al.
American Journal of Obstetrics & Gynecology MFM|November 20, 2023
Placenta accreta spectrum care infrastructure: an evidence-based review of needed resources supporting placenta accreta spectrum careGarrett D Fitzgerald, J M Newton, Lamia Atasi, et al.
Communications Physics|May 1, 2023
The Extremely Brilliant Source storage ring of the European Synchrotron Radiation FacilityPantaleo Raimondi, Chamseddine Benabderrahmane, Paul Berkvens, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Clinical Chemistry|July 30, 2015
Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and TrastuzumabMary Putt, Virginia Shalkey Hahn, James L Januzzi, et al.
Circulation. Cardiovascular Imaging|June 30, 2012
Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumabHeloisa Sawaya, Igal A Sebag, Juan Carlos Plana, et al.
Journal of the American College of Cardiology|December 3, 2013
Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumabBonnie Ky, Mary Putt, Heloisa Sawaya, et al.
JACC. Cardiooncology|October 4, 2021
Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology SocietyJoshua D Mitchell, Daniel A Cehic, Marita Morgia, et al.
Cancer|May 2, 2019
Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapyBiniyam G Demissei, Brian S Finkelman, Rebecca A Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2019
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple MyelomaRobert F Cornell, Bonnie Ky, Brendan M Weiss, et al.
Ecancermedicalscience|June 17, 2014
Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014)Michael Ewer, Luca Gianni, Fabrizio Pane, et al.
American Journal of Obstetrics and Gynecology|November 2, 2023
Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysisAli Javinani, Shohra Qaderi, Kamran Hessami, et al.
American Journal of Obstetrics & Gynecology MFM|November 20, 2023
Placenta accreta spectrum care infrastructure: an evidence-based review of needed resources supporting placenta accreta spectrum careGarrett D Fitzgerald, J M Newton, Lamia Atasi, et al.
Communications Physics|May 1, 2023
The Extremely Brilliant Source storage ring of the European Synchrotron Radiation FacilityPantaleo Raimondi, Chamseddine Benabderrahmane, Paul Berkvens, et al.
Pageof 6